Maria Alfaiate

Maria currently Heads New products Commercialization and Portfolio Strategy at Bayer Pharma. In this role, her team collaborates with Research and Development Teams providing commercial input and value assessments to shape future assets that bring value to patients, HCPs and society in general.  In the past 20 years she has held a number of different roles in different Pharmaceutical Companies such as AstraZeneca and MSD/Merck & Co, both in Country and Global capacity. She is passionate about innovation and science.